-+ 0.00%
-+ 0.00%
-+ 0.00%

Canon Stock And 2 Japanese Dividend Stocks Offering Steady Income

Simply Wall St·07/18/2026 04:41:16
Listen to the news

With bond markets shifting and inflation signals mixed across regions, many investors are looking for ways to keep cash flow steady without guessing where growth will come from next. That is where high quality dividend payers can help. The Dividend Powerhouses screener focuses on companies with more than a 5% yield that is covered by earnings, growing and relatively stable, so you are not just chasing high payouts for the sake of it. In this article, you will see three stocks from that list that show how this income focused theme can fit into a long term portfolio.

Canon (TSE:7751)

Overview: Canon is a Japan based global manufacturer of printers, cameras, medical imaging equipment and industrial machinery, supplying everything from office and commercial printing systems to CT scanners and semiconductor production tools under the Canon brand.

Operations: Canon generates most of its revenue from Printing at ¥2,493,937m, followed by Imaging at ¥1,088,690m, Medical at ¥585,356m and Industrial at ¥360,625m, with smaller contributions from Other and Corporate items.

Market Cap: ¥3.79t

Canon stands out on the Dividend Powerhouses list because it combines a long established cash generating business with a valuation that screens as meaningfully below estimated fair value, while recent earnings growth has been much stronger than its 5 year trend. A sizeable share buyback that retired around 4.5% of its stock supports per share metrics and signals management’s confidence in the company’s cash generation. At the same time, investors need to weigh weaker board independence, an unstable dividend track record and reliance on higher risk funding sources. These factors raise questions about resilience when conditions get tougher. The balance between attractive pricing, improving margins and these governance and funding flags is where the real story on Canon starts to get interesting.

Canon’s valuation gap, buybacks and dividend story appear to be starting to separate from old perceptions. The real question is whether the current price truly reflects its quality and governance trade offs in the 4 key rewards and 1 important warning sign

7751 Discounted Cash Flow as at Jul 2026
7751 Discounted Cash Flow as at Jul 2026

Daiichi Sankyo Company (TSE:4568)

Overview: Daiichi Sankyo Company is a Japan based pharmaceutical group that develops and sells prescription drugs globally, with a strong focus on cancer treatments such as Enhertu, Datroway and Vanflyta, alongside cardiovascular, metabolic, neurological and vaccine products.

Operations: Daiichi Sankyo Company generates around ¥2.1t in revenue from its Pharmaceutical Operation, with sales diversified across Japan, the United States, Europe and other regions.

Market Cap: ¥4.99t

Daiichi Sankyo Company is attracting attention because its antibody drug conjugate oncology portfolio, led by Enhertu and Datroway, sits at the center of multiple new approvals, reimbursement wins and partnerships with AstraZeneca and Merck. At the same time, the company leans heavily on a few blockbuster drugs, is spending heavily on R&D and ADC manufacturing capacity, and faces tighter drug pricing rules and rising competition, which puts pressure on margins and dividend coverage. For dividend investors, the combination of a roughly 3.6% yield, a rich oncology pipeline and a valuation that implies upside, set against funding risk and earnings quality questions, makes Daiichi Sankyo a complex but potentially rewarding income idea within this screener theme.

Daiichi Sankyo’s oncology engine, R&D spend and dividend yield are pulling in attention, but the real story sits in how the pieces fit together in the 2 key rewards and 2 important warning signs (1 is major!)

TSE:4568 Earnings & Revenue Growth as at Jul 2026
TSE:4568 Earnings & Revenue Growth as at Jul 2026

SoftBank (TSE:9434)

Overview: SoftBank is a Japan based telecom and digital services company that provides mobile and fixed line connectivity, broadband, cloud and AI solutions, e commerce, media, and cashless payment services to consumers and businesses through brands like PayPay and LINE Yahoo!.

Operations: SoftBank generates most of its revenue in Japan from Consumer services at ¥3,015.1b, Media & E Commerce at ¥1,667.0b, Distribution at ¥1,056.3b, Enterprise at ¥1,002.9b, and Financial services at ¥404.5b, with a smaller contribution from Other and unallocated items.

Market Cap: ¥10,558.4b

SoftBank may interest dividend focused investors because its telecom cash flows are tied to everyday connectivity while management is pushing hard into AI, data centers and digital payments through partnerships with groups like NVIDIA, Seven & i and Fujitsu. The PayPay and fintech ecosystem is already handling large payment volumes, and planned homegrown large language models and GPU as a service could deepen recurring revenue from enterprise clients. At the same time, higher debt, intense price competition in Japan’s wireless market and heavy spending on 5G and data centers mean returns on these projects are not guaranteed. The tension between its high tech ambitions, income appeal and funding risks is where the more detailed SoftBank story really starts to matter.

SoftBank’s telecom cash flows and AI ambitions appear to be starting to decouple, and the real twist lies in how its funding, dividends and growth plan stack up in the analysis report for SoftBank

TSE:9434 Earnings & Revenue Growth as at Jul 2026
TSE:9434 Earnings & Revenue Growth as at Jul 2026

The three stocks covered here are just a starting sample, as the full Dividend Powerhouses screen has uncovered 482 more companies with income profiles and narratives that may be just as compelling as those highlighted from the Dividend Powerhouses (3%+ Yield) screener. With Simply Wall St, you can quickly identify, filter and analyze the exact catalysts, dividend coverage metrics and storylines that matter most to you, so you can focus on the highest conviction opportunities in this 3%+ yield universe.

Take Control of Your Investment Journey

If SoftBank or any of these companies have caught your attention, register for FREE with Simply Wall St and add your companies to a Watchlist to monitor the share price against the fair value and track any new developments as they happen. Once you've made your move, manage your holdings with our Portfolio Command Center that filters out the noise to deliver only the most critical, actionable updates. Throughout your journey, our Community allows you to filter the best ideas from thousands of investor perspectives. By uncovering hidden catalysts and risks early, you'll accelerate your decision-making and stay one step ahead of the market.

Seeking Fresh Alternatives For Your Curiosity?

Markets move fast, and the freshest breakout ideas do not stay under the radar for long. Check these curated shortlists before the crowd catches on and get in early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.